Delix Therapeutics is a privately held biopharmaceutical company headquartered in Boston, Massachusetts, focused on transforming the treatment of brain health through neuroscience.
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Delix Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks Delix Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.